$1.84
0.105.75%
Pre-Market: Jan 24, 7:44 PM EDT
Harvard Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Harvard Bioscience using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-0.02 | $0.03 | -166.7 % |
Q2 | 2024-08-08 | $0 | $0.05 | -100.0 % |
Q1 | 2024-05-07 | $0.02 | $0.02 | 0.00 % |
Q4 | 2024-03-07 | $0.04 | $0.05 | -20.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $21.97M | $25.30M | -13.2 % |
Q2 | 2024-08-08 | $23.10M | $26.40M | -12.5 % |
Q1 | 2024-05-07 | $24.51M | $25.79M | -4.96 % |
Q4 | 2024-03-07 | $28.15M | $29.11M | -3.29 % |
Harvard Bioscience (HBIO) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.02, which missed the estimate of $0.03.
The Actual Revenue was $22M, which missed the estimate of $25.3M.
Browse earnings estimates, EPS, and revenue on all stocks.